UK-based semiconductor product maker DNA Electronics has raised the funding it needs to develop its Genalysis range of point-of-care genomic diagnostic products, with the majority of the capital being provided by its main shareholder, Edith Grove, a subsidiary of Malaysia-based conglomerate Genting Berhad.
Originally spun-out of Imperial College London, DNAe develops molecular interfaces and assays on a semiconductor platform.
Genalysis works as a sample-to-answer platform for nucleic acid detection, taking a swab or saliva sample and converting the DNA in it to a chip that can then be plugged into a USB stick or another electronic device to give a test result in about 30 minutes.
“I would like to thank Genting Berhad for their continued strong support of DNAe, which reflects their confidence in our strategy and capability,” said DNA Electronics CEO Chris Toumazou. “I am excited about embarking on this new chapter of growth and development of the company and making personalised genomic healthcare a tangible reality.”